Starting patients on the V-Go Disposable Insulin Delivery Device
|
|
- Ashley Short
- 8 years ago
- Views:
Transcription
1 Starting patients on the V-Go Disposable Insulin Delivery Device A simple guide for your practice For adult patients with Type 2 diabetes on basal insulin who need to take the next step
2 Identify appropriate candidates Add prandial control with V-Go Ideal patients to start on V-Go Elevated A1C (A1C 8%) 1 Basal insulin dose 30 U/day or 0.5 U/kg 2,3 After 12 weeks of basal insulin titration 4-6 Patients who may not be appropriate for V-Go Patients who have to make regular adjustments or modifications to their basal rate during a 24-hour period, or whose amount of insulin used at meals requires adjustments of less than 2-Unit increments, should not use V-Go as it may result in hypoglycemia. See the V-Go Instructions for Patient Use (Section 3) for the Indication, Warnings, and other safety information for V-Go. 2
3 Start V-Go: 3 easy steps 1. Write prescriptions for V-Go and insulin* 2. Ensure patients know how to use V-Go 3. Direct patients to call Valeritas Customer Care (VCC) * A U-100 fast-acting insulin should be used with V-Go. Humalog (insulin lispro, rdna origin) and NovoLog (insulin aspart, rdna origin) have been tested by Valeritas, Inc. and found to be safe for use in V-Go. Humalog is a registered trademark of Eli Lilly and Company. NovoLog is a registered trademark of Novo Nordisk A/S.
4 Meet patient needs with 3 V-Go options * * * *You can only click the Bolus Delivery Button 18 times in every 24-hour period. Each click of the Bolus Delivery Button delivers 2 Units of insulin (1 click = 2 Units). A co-pay reduction card is available for commercially insured patients. Download it at 4
5 Get patients started with 2 prescriptions V-Go Select the appropriate V-Go option Rx: Size: Package size: Sig: Disp: #30 Dosage form: Device V-Go 20 U, 30 U, 40 U Each Use 1 V-Go for 24 hours as directed NDC: V-Go 20: V-Go 30: V-Go 40: Insulin U-100 fast-acting insulin* 2 vials for V-Go 20 3 vials for V-Go 30 and V-Go 40 Click on Humalog or NovoLog Click unstructured and type in the Sig, Disp, and Pharmacy notes Example: For V-Go 30 insulin erx Sig: Disp: Pharmacy notes: Inject subcutaneous daily. #3 x 10 ml vials required per month for use in V-Go 30. Total daily dose will vary. Per FDA labeling, V-Go 30 requires 3 vials of insulin per month. * A U-100 fast-acting insulin should be used with V-Go. Humalog (insulin lispro, rdna origin) and NovoLog (insulin aspart, rdna origin) have been tested by Valeritas, Inc. and found to be safe for use in V-Go. Humalog is a registered trademark of Eli Lilly and Company. NovoLog is a registered trademark of Novo Nordisk A/S.
6 V-Go dosing Initiate Goal: Reach 50/50 split on the daily basal-bolus insulin dose 3,7 Adults on basal insulin only (± OADs) 3,8 Patient s body weight 220 lb >220 lb x 0.45 kg/lb x 0.5 U/kg Basal rate V-Go 20 Units/24 hours Basal rate V-Go 30 Units/24 hours Bolus dosing 2 clicks/meal 1 click = 2 Units Bolus dosing 3 clicks/meal 1 click = 2 Units When appropriate, consider advising patients to click when they snack. Ensure that your patients have a plan to manage hypoglycemia and hyperglycemia. 6
7 V-Go dosing Titrate Goal: Reach 50/50 split on the daily basal-bolus insulin dose 3,7 Improving postprandial glucose can help reduce fasting and preprandial glucose levels and improve control As with any insulin therapy: Titration with V-Go is critical to improving glycemic control. First optimize bolus Adjust basal if needed If mealtime blood glucose is consistently not at goal, add clicks weekly until optimized After optimizing bolus dosing, increase the V-Go option if A1C is not at goal or fasting glucose is still elevated
8 Make sure patients know how to use V-Go Easy to fill Patients fill a new V-Go with insulin each day. Easy to apply Patients simply place V-Go on their skin and press the Needle Button to start the basal rate. Easy to use Patients use the Bolus Ready Button and Bolus Delivery Button at mealtimes. (1 click = 2 Units) For the simple steps on how to fill, apply, and use V-Go, refer to the print, interactive, or video versions of the Quick Reference Guide at Ensure that patients understand basal-bolus therapy and that they have a plan to manage hypoglycemia and hyperglycemia. 8
9 Direct patients to enroll in Valeritas Customer Care (VCC) Comprehensive benefits for you and your patients, including a 1:1 partnership with a dedicated representative and 24/7 support at Benefits for your patients Benefits for you Responds to V-Go questions live anytime 24/7 assistance Decreases call frequency to your office and offers patient support after hours Provides expert personalized insurance guidance and benefits investigation Reimbursement help Fewer phone calls and contacts with insurance companies Makes obtaining V-Go and using the co-pay card easy Pharmacy support Patients easily get the product you prescribe for them Provides initial instruction plus follow-up to help patients succeed with V-Go V-Go use Lessens staff time needed to show patients how to fill, apply, and use V-Go Keep your patients on track with regular calls over the first 90 days Follow-up calls Promote patient compliance while reducing the need for office follow-up Provides online access to practical information about diabetes and V-Go V-Go Life TM Self-Management Program Helps keep patients motivated and encourages compliance Valeritas does not give medical advice about insulin therapy. Patients should discuss all medical therapies with you and follow your instructions.
10 Take the next step V-Go delivers a continuous preset basal rate of insulin plus on-demand bolus dosing at mealtimes, which may help improve glycemic control. 9,
11 Notes
12 3 easy steps to starting your patients on V-Go 1. Write prescriptions for V-Go and insulin* 2. Ensure patients know how to use V-Go 3. Direct patients to call Valeritas Customer Care (VCC) We re here 24/7 You and your patients can find help day or night. Call or visit Important Risk Information: If regular adjustments or modifications to the basal rate of insulin are required in a 24-hour period, or if the amount of insulin used at meals requires adjustments of less than 2-Unit increments, use of the V-Go Disposable Insulin Delivery Device may result in hypoglycemia. The following conditions may occur during insulin therapy with V-Go: hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose). Other adverse reactions associated with V-Go use include skin irritation from the adhesive pad or infections at the infusion site. V-Go should be removed before any magnetic resonance imaging (MRI) testing. *A U-100 fast-acting insulin should be used with V-Go. Humalog (insulin lispro, rdna origin) and NovoLog (insulin aspart, rdna origin) have been tested by Valeritas, Inc. and found to be safe for use in V-Go. References: 1. Nathan DM, et al. Diabetes Care. 2009;32(1): Inzucchi SE, et al. Diabetes Care. 2012;35(6): Edelman SV, et al. Diabetes Technol Ther. 2010;12(8): Strange P. J Diabetes Sci Technol. 2007;1(4): Riddle MC, et al. Diabetes Care. 2003;26(11): In the treat-to-target study. Accessed September 24, Bode BW, et al. Diabetes Metab Res Rev. 2002;18(suppl 1):S14-S Data on file. Valeritas, Inc. 9. Kapitza C, et al. J Diabetes Sci Technol. 2008;2(1): Holman RR, et al. N Engl J Med. 2007;357(17): Holman RR, et al. N Engl J Med. 2009;361(18): Woerle HJ, et al. Diabetes Res Clin Pract. 2007;77(2): Riddle M, et al. Diabetes Care. 2011;34(12): Grunberger G, et al. Poster presented at: American Association of Clinical Endocrinologists 23rd Annual Scientific and Clinical Congress; May 14-18, 2014; Las Vegas, NV. Abstract Rosenfeld CR, et al. Endocr Pract. 2012;18(5): Omer A, et al. Poster presented at: American Diabetes Association 73rd Scientific Sessions; June 21-25, 2013; Chicago, IL. Abstract 980-P. V-Go is a registered trademark of Valeritas, Inc. 12 ART-712 Rev: A 09/ Valeritas, Inc.
Insulin Administration: What You Don t Know May Hurt Your Patient
Insulin Administration: What You Don t Know May Hurt Your Patient Jaime A. Davidson, MD, FACP, MACE Clinical Professor of Internal Medicine UT Southwestern Medical Center Dallas, Texas Jaime A. Davidson,
More informationIntensifying Insulin Therapy
Intensifying Insulin Therapy Rick Hess, PharmD, CDE, BC-ADM Associate Professor Gatton College of Pharmacy, Department of Pharmacy Practice East Tennessee State University Johnson City, Tennessee Learning
More informationIntensive Insulin Therapy in Diabetes Management
Intensive Insulin Therapy in Diabetes Management Lillian F. Lien, MD Medical Director, Duke Inpatient Diabetes Management Assistant Professor of Medicine Division of Endocrinology, Metabolism, & Nutrition
More informationPrior Authorization Guideline
Prior Authorization Guideline Guideline: PC - Apidra, Levemir Therapeutic Class: Hormones and Synthetic Substitutes Therapeutic Sub-Class: Antidiabetic Agents Client: CA, CO, NV, OK, OR, WA and AZ Approval
More informationDiabetes Medications: Insulin Therapy
Diabetes Medications: Insulin Therapy Courtesy Univ Texas San Antonio Eric L. Johnson, M.D. Department of Family and Community Medicine Diabetes and Insulin Type 1 Diabetes Autoimmune destruction of beta
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
Afrezza Page 1 of 6 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Afrezza (human insulin) Prime Therapeutics will review Prior Authorization requests Prior Authorization
More informationIntensifying Insulin In Type 2 Diabetes
Intensifying Insulin In Type 2 Diabetes Eric L. Johnson, M.D. Associate Professor Department of Family and Community Medicine University of North Dakota School of Medicine and Health Sciences Assistant
More informationInitiation and Adjustment of Insulin Regimens for Type 2 Diabetes
PL Detail-Document #300128 This Detail-Document accompanies the related article published in PHARMACIST S LETTER / PRESCRIBER S LETTER January 2014 Initiation and Adjustment of Insulin Regimens for Type
More informationPresented By: Dr. Nadira Husein
Presented By: Dr. Nadira Husein I have no conflict of interest Disclosures I have received honoraria/educational grants from the following: Novo Nordisk, Eli Lilly, sanofi-aventis, Novartis, Astra Zeneca,
More information8/6/2015. Diabetes Educator Needed: Transitioning Inpatient Persons with Diabetes on U-500 Regular Insulin to Discharge Safely
Diabetes Educator Needed: Transitioning Inpatient Persons with Diabetes on U-500 Regular Insulin to Discharge Safely Carol A. Biondi MSN, RN, CDE Diabetes Nurse Specialist Tampa General Hospital Tampa,
More informationInsulin: Breaking Barriers Enhancing Therapies. Jerry Meece, RPh, FACA, CDE jmeece12@cooke.net
Insulin: Breaking Barriers Enhancing Therapies Jerry Meece, RPh, FACA, CDE jmeece12@cooke.net Questions To Address Who are candidates for insulin? When do we start insulin? How do the different types of
More informationThe basal plus strategy. Denis Raccah, MD, PhD Professor of Medicine University Hospital Sainte Marguerite Marseille FRANCE
The basal plus strategy Denis Raccah, MD, PhD Professor of Medicine University Hospital Sainte Marguerite Marseille FRANCE ADA/EASD guidelines recommend use of basal insulin as early as the second step
More informationINSULIN ALGORITHM FOR TYPE 2 DIABETES MELLITUS IN CHILDREN 1 AND ADULTS
Publication # 45-11647 Targets*
More informationDiabetes: When To Treat With Insulin and Treatment Goals
Diabetes: When To Treat With Insulin and Treatment Goals Lanita. S. White, Pharm.D. Director, UAMS 12 th Street Health and Wellness Center Assistant Professor of Pharmacy Practice, UAMS College of Pharmacy
More informationInstructions for Patient Use
Customer Care 1-866-881-1209 Using the V-Go Disposable Insulin Delivery Device Instructions for Patient Use Training on the V-Go is important. If you have not been previously trained, speak to a Valeritas
More informationDiabetes and Technology. Disclosures Certified Insulin Pump Trainer for: Animas Medtronic Diabetes Omnipod. Rebecca Ray, MSN, APRN, FNP-C
Diabetes and Technology Rebecca Ray, MSN, APRN, FNP-C Insulin Pump Therapy and Continuous Glucose Monitoring In Patients with Type 2 Diabetes Page 1 Disclosures Certified Insulin Pump Trainer for: Animas
More informationINSULIN TREATMENT FOR TYPE 2 DIABETES MANAGEMENT
INSULIN TREATMENT FOR TYPE 2 DIABETES MANAGEMENT APIRADEE SRIWIJITKAMOL DIVISION OF ENDOCRINOLOGY AND METABOLISM DEPARTMENT OF MEDICINE FACULTY OF MEDICINE SIRIRAJ HOSPITOL QUESTION 1 1. ท านเคยเป นแพทย
More informationInsulin: A Practice Update. Department of Nursing Staff Development Elizabeth Borgelt, MS, RN
Insulin: A Practice Update Department of Nursing Staff Development Elizabeth Borgelt, MS, RN Learning Outcome The learner will be able to identify the different types of insulins available, their actions,
More informationTherapy Insulin Practical guide to Health Care Providers Quick Reference F Diabetes Mellitus in Type 2
Ministry of Health, Malaysia 2010 First published March 2011 Perkhidmatan Diabetes dan Endokrinologi Kementerian Kesihatan Malaysia Practical guide to Insulin Therapy in Type 2 Diabetes Mellitus Quick
More informationInsulin Algorithm for Type 2 Diabetes Mellitus in Children and Adults
Insulin Algorithm for Type 2 Diabetes Mellitus in Children and Adults Stock # 45-11647 Revised 10/28/10 Glycemic Goals 1,2 Individualize goal based on patient risk factors A1c 6%
More informationInsulin Initiation and Intensification
Insulin Initiation and Intensification ANDREW S. RHINEHART, MD, FACP, CDE MEDICAL DIRECTOR AND DIABETOLOGIST JOHNSTON MEMORIAL DIABETES CARE CENTER Objectives Understand the pharmacodynamics and pharmacokinetics
More informationInsulin Delivery Options: Inhale, Inject, and Infuse. Traci Evans, A.N.P., B.C.-A.D.M. Nurse Practitioner The Diabetes Center Ocean Springs, MS
Insulin Delivery Options: Inhale, Inject, and Infuse Traci Evans, A.N.P., B.C.-A.D.M. Nurse Practitioner The Diabetes Center Ocean Springs, MS Objectives Identify three ways patients are able to utilize
More informationDonovan Victorine Pharm.D. BCACP Clinical Pharmacy Specialist Boise VA Medical Center. U-500 Insulin
Donovan Victorine Pharm.D. BCACP Clinical Pharmacy Specialist Boise VA Medical Center U-500 Insulin Understand differences between U-500 concentrated insulin and standard insulin formulations Recognize
More informationDiabetes and the Elimination of Sliding Scale Insulin. Date: April 30 th 2013. Presenter: Derek Sanders, D.Ph.
Diabetes and the Elimination of Sliding Scale Insulin Date: April 30 th 2013 Presenter: Derek Sanders, D.Ph. Background Information Epidemiology and Risk Factors Diabetes Its Definition and Its Impact
More informationAlgorithms for Glycemic Management of Type 2 Diabetes
KENTUCKY DIABETES NETWORK, INC. Algorithms for Glycemic Management of Type 2 Diabetes The Diabetes Care Algorithms for Type 2 Diabetes included within this document are taken from the American Association
More informationINPATIENT DIABETES MANAGEMENT Robert J. Rushakoff, MD Professor of Medicine Director, Inpatient Diabetes University of California, San Francisco
INPATIENT DIABETES MANAGEMENT Robert J. Rushakoff, MD Professor of Medicine Director, Inpatient Diabetes University of California, San Francisco CLINICAL RECOGNITION Background: Appropriate inpatient glycemic
More informationFinally, the right fit for your insulin needs. www.tandemdiabetes.com
Finally, the right fit for your insulin needs. www.tandemdiabetes.com (Actual Size) For convenience and ease of use, the t:flex TM Insulin Pump just fits. It is designed to help make your day-to-day insulin
More informationFor Educational Use Only - Not for Detailing or Distribution
This document is intended for healthcare professionals practicing in the United States and may contain information that has not been approved by the FDA. It is supplied to you as a professional courtesy
More informationOnset Peak Duration Comments
Rapid- Acting 5-15 minutes 0.5-3 hours 3-5 hours Meal should be available before administering, ideally taking within 10 minutes of eating). Good in refrigerator (36-46 F) until expiration date. Protect
More informationPresent and Future of Insulin Therapy: Research Rationale for New Insulins
Present and Future of Insulin Therapy: Research Rationale for New Insulins Current insulin analogues represent an important advance over human insulins, but clinically important limitations of these agents
More informationPrior Authorization Guideline
Prior Authorization Guideline Guideline: PC (CO) - Insulin Delivery Systems Therapeutic Class: Hormones and Synthetic Substitutes Therapeutic Sub-Class: Insulin Delivery Systems Client: CO Approval Date:
More informationA Simplified Approach to Initiating Insulin. 4. Not meeting glycemic goals with oral hypoglycemic agents or
A Simplified Approach to Initiating Insulin When to Start Insulin: 1. Fasting plasma glucose (FPG) levels >250 mg/dl or 2. Glycated hemoglobin (A1C) >10% or 3. Random plasma glucose consistently >300 mg/dl
More informationPeople with type 2 diabetes mellitus (T2DM) often require
DIABETES TECHNOLOGY & THERAPEUTICS Volume 12, Supplement 1, 2010 ª Mary Ann Liebert, Inc. DOI: 10.1089=dia.2009.0192 Insulin Pump Use in Type 2 Diabetes Bruce W. Bode, M.D., F.A.C.E. Abstract Continuous
More informationNumerous studies have demonstrated that utilization
DIABETES TECHNOLOGY & THERAPEUTICS Volume 18, Supplement 2, 2016 ª Mary Ann Liebert, Inc. DOI: 10.1089/dia.2015.0369 ORIGINAL ARTICLE Use of Glucose Rate of Change Arrows to Adjust Insulin Therapy Among
More informationInsulin T Y P E 1 T Y P E 2
T Y P E 1 T Y P E 2 INSULIN There are many different insulins for many different situations and lifestyles. This section should help you and your doctor decide which insulin or insulins are best for you.
More informationGlycemic Control Initiative: Insulin Order Set Changes Hypoglycemia Nursing Protocol
Glycemic Control Initiative: Insulin Order Set Changes Hypoglycemia Nursing Protocol Ruth LaCasse Kalish, RPh Department of Pharmacy Objectives Review the current practice at UConn Health with sliding
More informationCLASS OBJECTIVES. Describe the history of insulin discovery List types of insulin Define indications and dosages Review case studies
Insulins CLASS OBJECTIVES Describe the history of insulin discovery List types of insulin Define indications and dosages Review case studies INVENTION OF INSULIN 1921 The first stills used to make insulin
More informationInsulin therapy in type 2 diabetes When and how? Disclosures. Learning Objectives. None relevant to today s talk
Insulin therapy in type 2 diabetes When and how? Cecilia C Low Wang, MD Univ Colorado AMC SOM Department of Medicine Division of Endocrinology, Metabolism, and Diabetes Disclosures None relevant to today
More informationChapter 2 Subcutaneous Insulin: A Guide for Dosing Regimens in the Hospital
Chapter 2 Subcutaneous Insulin: A Guide for Dosing Regimens in the Hospital Karen Barnard, Bryan C. Batch, and Lillian F. Lien Keywords Basal-bolus insulin Prandial insulin Basal insulin Correction dose
More informationInsulin Therapy In Type 2 DM. Sources of support. Agenda. Michael Fischer, M.D., M.S. The underuse of insulin Insulin definition and types
Insulin Therapy In Type 2 DM Michael Fischer, M.D., M.S. Sources of support NaRCAD is supported by a grant from the Agency for Healthcare Research and Quality My current research projects are funded by
More informationThe Importance of Using Insulin Safely. Learning Objectives
The Importance of Using Insulin Safely Victor Tran, PharmD PGY 1 Pharmacy Resident Ambulatory Care Diabetes Symposium November 12, 2015 Learning Objectives List the potential adverse drug events of insulin
More informationHealth Professional s. Guide to INSULIN PUMP THERAPY
Health Professional s Guide to INSULIN PUMP THERAPY Table of Contents Introduction Presenting Insulin Pump Therapy to Your Patients When Your Patient Chooses the Pump Estimates for Starting Insulin Pump
More informationType 2 Diabetes Adult Outpatient Insulin Guidelines Sutter Medical Foundation. February 2011.
Type 2 Diabetes Adult Outpatient Insulin Guidelines. GENERAL RECOMMENDATIONS Start insulin if A1C and glucose levels are above goal despite optimal use of other diabetes medications. (Consider insulin
More informationClinical Policy Title: Disposable Continuous Subcutaneous Insulin Infusion Pumps
Clinical Policy Title: Disposable Continuous Subcutaneous Insulin Infusion Pumps Clinical Policy Number: 06.02.01 Effective Date: March 1, 2014 Initial Review Date: Nov. 20 th, 2013 Most Recent Review
More informationINSULINThere are. T y p e 1 T y p e 2. many different insulins for
T y p e 1 T y p e 2 INSULINThere are many different insulins for Characteristics The three characteristics of insulin are: Onset. The length of time before insulin reaches the bloodstream and begins lowering
More informationADJUSTING INSULIN DOSES CONFLICTS OF INTEREST
ADJUSTING INSULIN DOSES CONFLICTS OF INTEREST Vahid Mahabadi, MD Research grants from Sanofi and Amylin Pharmaceutical Companies Mayer B. Davidson, MD Advisory Board Sanofi Pharmaceutical Company Chief
More informationContinuous Subcutaneous Insulin Infusion (CSII)
IMPORTANCE OF FOCUS CSII (Insulin pumps) have been used for more than 35 years. In the U.S. in 2005, the level of insulin pump penetration was estimated at 20 to 30% in patients with type 1 diabetes mellitus
More informationThe Diabetes Self Management Insulin Pump Therapy Program
The Diabetes Self Management Insulin Pump Therapy Program Is part of a Nationally recognized program taught by CPT s Offers classes during the daytime in a three part series: PRE-PUMP CLASS SALINE START
More informationInsulin/Diabetes Calculations
Insulin/Diabetes Calculations Dr. Aipoalani St Lukes Endocrinology Goals Describe various calculations for insulin dosing Understand importance of the total daily dose (TDD) of insulin Be able to calculate
More informationFunc%onal insulin therapy: rela%onship to carbohydrate intake
Func%onal insulin therapy: rela%onship to carbohydrate intake Prof. Andrej Janež MD, PhD University Medical Centre Ljubljana, Slovenia Conflict of interests Merck Sharp&Dohme, Novo Nordisk, NovarEs, Boehringer
More informationObjectives PERINATAL INSULIN PUMPS: BASICS FOR NURSES. Historical Perspective. Insulin Pumps in Pregnancy. Insulin Pumps in the US
Objectives PERINATAL INSULIN PUMPS: BASICS FOR NURSES Jo M. Kendrick, APN BC, CDE jkendric@utmck.edu Describe indications and contraindications for insulin pump use in hospitalized patients Differentiate
More informationInsulin Therapy. Endocrinologist. H. Delshad M.D. Research Institute For Endocrine Sciences
Insulin Therapy H. Delshad M.D Endocrinologist Research Institute For Endocrine Sciences Primary Objectives of Effective Management A1C % 9 8 Diagnosis SBP mm Hg LDL mg/dl 7 145 130 140 100 Reduction of
More informationRole of Insulin Analogs in Type 2 Diabetes References
1. American Association of Clinical Endocrinologists/American College of Endocrinology Diabetes Recommendations Implementation Writing Committee. ACE/AACE Consensus conference on the implementation of
More informationMost patients with T2DM will eventually require insulin therapy. ADA Glycemic Control Targets. What are some of the obstacles?
ADA Glycemic Control Targets A1C < 7% Preprandial plasma glucose 70-130 mg/dl Postprandial plasma glucose (PPG)
More informationINSULIN FOR GESTATIONAL and PREGESTATIONAL DIABETES
INSULIN FOR GESTATIONAL and PREGESTATIONAL DIABETES There have been several changes in the management of diabetes during pregnancy, including the use of insulin analogs. The Sweet Success Guidelines, revised
More informationManaging the Hospitalized Patient on Insulin: Care Transition. Catie Prinzing MSN, APRN, CNS
Managing the Hospitalized Patient on Insulin: Care Transition Catie Prinzing MSN, APRN, CNS Diabetes and Hospitalization People with DM are hospitalized 3x more frequently than patients without diabetes
More informationA guidebook for people with diabetes
A guidebook for people with diabetes This booklet is designed to supplement, not replace, your doctor s advice. Please consult your doctor if you have any questions about what you read. You ll learn how
More informationClinical Policy Title: Disposable Continuous Subcutaneous Insulin Infusion Pumps
Clinical Policy Title: Disposable Continuous Subcutaneous Insulin Infusion Pumps Clinical Policy Number: 06.02.01 Effective Date: March 1, 2014 Initial Review Date: Nov. 20, 2013 Most Recent Review Date:
More informationHigh Dose Insulin Therapy: The case for CONCENTRATED Insulin
High Dose Insulin Therapy: The case for CONCENTRATED Insulin 21 st Annual Diabetes Fall Symposium Charleston, SC Wendy Lane MD September 18, 2015 Mountain Diabetes and Endocrine Center Asheville, North
More informationResident s Guide to Inpatient Diabetes
Resident s Guide to Inpatient Diabetes 1. All patients with diabetes of ANY TYPE, regardless of reason for admission, must have a Hemoglobin A1C documented in the medical record within 24 hours of admission
More informationBASAL BOLUS INSULIN FOR MEDICAL- SURGICAL INPATIENTS
BASAL BOLUS INSULIN FOR MEDICAL- SURGICAL INPATIENTS C O N T A C T D I A B E T E S S E R V I C E S F O R M O R E I N F O R M A T I O N 8 4 7-9 1 7-6 9 0 7 THIS SLIDE PRESENTATION WAS PREPARED BY SUE DROGOS,
More informationInsulin Infusion Pumps
Medical Coverage Policy Insulin Infusion Pumps EFFECTIVE DATE: 09/01/2004 POLICY LAST UPDATED: 08/06/2013 OVERVIEW The policy addresses insulin infusion pumps that are worn externally and those that are
More informationInsulin Pump Therapy and Continuous Glucose Sensor Use in the Management of Diabetes Mellitus
Insulin Pump Therapy and Continuous Glucose Sensor Use in the Management of Diabetes Mellitus Louis Haenel, IV, DO, FACOI, FACE Endocrinology Roper Hospital Charleston, SC Dr. Louis Haenel IV has disclosed
More informationMultiple-dose insulin injection therapy in patients with type 2 diabetes using a basal-bolus regimen, team management, and nutrition education
Multiple-dose insulin injection therapy in patients with type 2 diabetes using a basal-bolus regimen, team management, and nutrition education Alison Baldwin, BS University of South Carolina School of
More informationUW MEDICINE PATIENT EDUCATION. Using Insulin. Basic facts about insulin and self-injection. What is insulin? How does diabetes affect the body?
UW MEDICINE PATIENT EDUCATION Using Insulin Basic facts about insulin and self-injection This handout explains what insulin is, the different types of insulin, how to store it, how to give an injection
More informationPrimary Care Type 2 Diabetes Update
Primary Care Type 2 Diabetes Update May 16, 2014 Presented by: Barb Risnes APRN, BC-ADM, CDE Objectives: Discuss strategies to address common type 2 diabetes patient management challenges Review new pharmacological
More informationHow to Switch Between Insulin Products
Detail-Document #251005 This Detail-Document accompanies the related article published in PHARMACIST S LETTER / PRESCRIBER S LETTER October 2009 ~ Volume 25 ~ Number 251005 How to Switch Between Insulin
More informationType 2 Diabetes - Pros and Cons of Insulin Administration
Do we need alternative routes of insulin administration (inhaled insulin) in Type 2 diabetes? Cons: Suad Efendic Karolinska Institutet, Sweden The Diabetes Management Situation Today Diabetes is a growing
More informationINSULIN AND INCRETIN THERAPIES: WHAT COMBINATIONS ARE RIGHT FOR YOUR PATIENT?
INSULIN AND INCRETIN THERAPIES: WHAT COMBINATIONS ARE RIGHT FOR YOUR PATIENT? MARTHA M. BRINSKO, MSN, ANP-BC CHARLOTTE COMMUNITY HEALTH CLINIC CHARLOTTE, NC Diagnosed and undiagnosed diabetes in the United
More informationInsulin Pump Therapy Is It Right for You? Compliments of Novo Nordisk Pharmaceuticals, Inc.
Insulin Pump Therapy Is It Right for You? Compliments of Novo Nordisk Pharmaceuticals, Inc. Who should consider the insulin pump option? More and more people with diabetes are switching from injecting
More informationDiabetes Mellitus. Melissa Meredith M.D. Diabetes Mellitus
Melissa Meredith M.D. Diabetes mellitus is a group of metabolic diseases characterized by high blood glucose resulting from defects in insulin secretion, insulin action, or both Diabetes is a chronic,
More informationIntroduction to Insulin. Your guide to taking insulin
Introduction to Insulin Your guide to taking insulin Introduction Insulin helps control the level of blood glucose in the body. Everyone with type 1 diabetes must take insulin, and many people with type
More informationPump Therapy Indications:
Insulin Pumping Getting Started March 7, 2008 Clinical Pearls To understand the rational behind pump therapy To explore patient preferences for and against insulin pump therapy Realistic expectations for
More information4/7/2015 CONFLICT OF INTEREST DISCLOSURE OBJECTIVES. Conflicts of Interest None Heather Rush. Heather M. Rush, APRN, CDE Louisville, KY
Heather M. Rush, APRN, CDE Louisville, KY CONFLICT OF INTEREST DISCLOSURE Conflicts of Interest None Heather Rush A conflict of interest exists when an individual is in a position to profit directly or
More informationUser guide Basal-bolus Insulin Dosing Chart: Adult
Contacts and further information Local contact Clinical pharmacy or visiting pharmacy Diabetes education service Director of Medical Services Visiting or local endocrinologist or diabetes physician For
More informationOFFICE OF CATHOLIC SCHOOLS DIOCESE OF ARLINGTON DIABETES MEDICAL MANAGEMENT PLAN Page 1 of 5 TO BE COMPLETED BY PARENT OR GUARDIAN
PART I OFFICE OF CATHOLIC SCHOOLS DIOCESE OF ARLINGTON DIABETES MEDICAL MANAGEMENT PLAN Page 1 of 5 TO BE COMPLETED BY PARENT OR GUARDIAN Student School Date of Birth Date of Diagnosis Grade/ Teacher Physical
More informationInsulin delivery using pen devices
Insulin delivery using pen devices Simple-to-use tools may help young and old alike Nancy J. V. Bohannon, MD Preview: Clinical trials have convincingly demonstrated that improved glycemic control significantly
More informationIMPROVED METABOLIC CONTROL WITH A FAVORABLE WEIGHT PROFILE IN PATIENTS WITH TYPE 2 DIABETES TREATED WITH INSULIN GLARGINE (LANTUS ) IN CLINICAL
464 IMPROVED METABOLIC CONTROL WITH A FAVORABLE WEIGHT PROFILE IN PATIENTS WITH TYPE 2 DIABETES TREATED WITH INSULIN GLARGINE (LANTUS ) IN CLINICAL PRACTICE STEPHAN A SCHREIBER AND ANIKA RUßMAN ABSTRACT
More informationInsulin Pump Therapy
Introduction The first insulin pumps, or continuous subcutaneous insulin infusion systems (CSII), were introduced in 1976. These early pumps were the size of a backpack and were unreliable. Since then,
More informationSafety and Effectiveness of Modern Insulin Therapy: The Value of Insulin Analogs
STEPHEN BRUNTON, MD Cabarrus Family Medicine Residency Program, Charlotte, NC Safety and Effectiveness of Modern Insulin Therapy: Dr Brunton is director of faculty development at the Cabarrus Family Medicine
More informationTen Ways to Prevent Insulin-Use Errors in Your Hospital. ASHP Research and Education Foundation May 14, 2014
Ten Ways to Prevent Insulin-Use Errors in Your Hospital ASHP Research and Education Foundation May 14, 2014 To Ask Questions and Adjust the Control Panel Expand or Collapse Type your question here Faculty
More information10 to 30 minutes ½ to 3 hours 3 to 5 hours. 30 60 minutes 1 to 5 hours 8 hours. 1 to 4 hours
Insulin Action There are several types of insulin. They are classified by how long they act: very fast, fast, slow and very slow acting. Each type of insulin has a certain time period in which it works.
More informationsecond of a two-article series. The first, Clinical Considerations for Insulin
Navid Saadat, MD Clinical Considerations for Insulin Pharmacotherapy in Ambulatory Care, Part Two: Review of Primary Literature and an Evidence-Based Approach for Treatment Maria Miller Thurston, 1 John
More informationBasal and Bolus Insulin 7/16/2014. Jackie Aday RN, BSN, CDE Jeni Neighbors RN, BSN, CDE. BASAL: Small amount of insulin infused every few minutes
Jackie Aday RN, BSN, CDE Jeni Neighbors RN, BSN, CDE Insulin Pump Therapy Open looped system in which a small amount of insulin is continuously infused through a cannula or needle (basal rate) Larger doses
More informationScottish Medicines Consortium
Scottish Medicines Consortium insulin glulisine for subcutaneous injection 100 units/ml (Apidra ) No. (298/06) Sanofi Aventis 4 August 2006 The Scottish Medicines Consortium (SMC) has completed its assessment
More informationWhy is Insulin so Important?
Insulin Therapy Why is Insulin so Important? If the glucose stays in your blood it doesn t do your cells (body) any good The glucose has to get inside the cells for the body to use it What Does Insulin
More informationHEALTH SERVICES POLICY & PROCEDURE MANUAL
Page 1 of 5 PURPOSE To assure that DOP inmates with Diabetes, who require insulin therapy, are receiving high quality Primary Care for their condition. POLICY All DOP Primary Care Providers are to follow
More informationDiabetes Management Tube Feeding/Parenteral Nutrition Order Set (Adult)
Review Due Date: 2016 May PATIENT CARE ORDERS Weight (kg) Known Adverse Reactions or Intolerances DRUG No Yes (list) FOOD No Yes (list) LATEX No Yes ***See Suggestions for Management (on reverse)*** ***If
More informationManaging the U Managing the U--500 500 Patient as a Surg as a Sur ical Inpatient
Managing the U-500 Patient as a Surgical Inpatient Tyler Fischback Pharmacy Specialist St. Clare Hospital I have no conflicts of interest to disclose The Case DM is a 37 y.o.. developmentally delayed T2DM
More informationTypes of insulin and How to Use Them
Diabetes and Insulin Pumps Amy S. Pullen Pharm.D ISHP Spring Meeting April 2012 Objectives Describe the different types of insulin used in diabetes Identify the types of insulin that are compatible with
More informationStarting Insulin. Disclosures. Starting Insulin. Ronnie Aronson MD, FRCPC, FACE Executive Director, LMC Endocrinology Centres
Starting Insulin Ronnie Aronson MD, FRCPC, FACE Executive Director, LMC Endocrinology Centres Disclosures Scientific Consultant Abbott, AstraZeneca, GSK, Merck, Sanofi-Aventis, Janssen- Ortho, Servier
More informationSanofi Reports Positive Phase 3 Results for Toujeo (insulin glargine [rdna origin] injection, 300 U/mL)
PRESS RELEASE Sanofi Reports Positive Phase 3 Results for Toujeo (insulin glargine [rdna origin] injection, 300 U/mL) Meta-analysis of three late-stage trials in people with type 2 diabetes shows decreases
More informationOverview of Insulin and Non-Insulin Delivery Devices In the Treatment of Diabetes
Overview of Insulin and Non-Insulin Delivery Devices In the Treatment of Diabetes Michele Pisano, PharmD, CGP INTRODUCTION Diabetes affects 20.9 million people in the U.S. and 347 million people worldwide.
More informationShort-acting insulin analogues vs. regular human insulin in type 2 diabetes: a meta-analysis
ORIGINAL ARTICLE doi: 10.1111/j.1463-1326.2008.00934.x Short-acting insulin analogues vs. regular human insulin in type 2 diabetes: a meta-analysis E. Mannucci, M. Monami and N. Marchionni Department of
More informationALVIN INDEPENDENT SCHOOL DISTRICT Diabetes Medical Management Plan
ALVIN INDEPENDENT SCHOOL DISTRICT Diabetes Medical Management Plan of Plan: School Year (must be current): This plan should be completed by the student s personal health care team and parents/guardian.
More informationINSULIN INTENSIFICATION: Taking Care to the Next Level
INSULIN INTENSIFICATION: Taking Care to the Next Level By J. Robin Conway M.D., Diabetes Clinic, Smiths Falls, ON www.diabetesclinic.ca Type 2 Diabetes is an increasing problem in our society, due largely
More informationGet Primed on Pumps: A beginners guide to Insulin Pump Therapy
Get Primed on Pumps: A beginners guide to Insulin Pump Therapy Advantages of insulin pump therapy There are many advantages to using an insulin pump. Anyone can do it with the right training and support.
More informationCalculating Insulin Dose
Calculating Insulin Dose First, some basic things to know about insulin: Approximately 40-50% of the total daily insulin dose is to replace insulin overnight, when you are fasting and between meals. This
More informationSession 5: Insulin: Tried and True - Update on Best Practices in Clinical Use and Patient Adherence Learning Objectives
Session 5: Insulin: Tried and True - Update on Best Practices in Clinical Use and Patient Adherence Learning Objectives 1. Design strategies to help patients overcome cultural barriers to using insulin,
More informationMEDICAL COVERAGE POLICY. SERVICE: Insulin Pump and Continuous Glucose Monitoring. PRIOR AUTHORIZATION: Required. POLICY:
Important note Even though this policy may indicate that a particular service or supply may be considered covered, this conclusion is not based upon the terms of your particular benefit plan. Each benefit
More information